Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate

Bausch + Lomb Initiates Phase 3 Program for Glaucoma Drug Candidate

Filed under: drug treatment programs in san diego

"There is a need for more effective, safer and better tolerated therapies to lower IOP," said Robert N. Weinreb, M.D., chairman & distinguished professor of Ophthalmology, University of California San Diego and director, Shiley Eye Center and Hamilton …
Read more on Marketwire (press release)

 

FDA APPROVES THREE NEW DRUG TREATMENTS FOR TYPE 2 DIABETES

Filed under: drug treatment programs in san diego

January 29, 2013 (San Diego)–The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin …
Read more on East County Magazine

 

ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188

Filed under: drug treatment programs in san diego

SAN DIEGO, Jan. 30, 2013 /PRNewswire/ — ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it has initiated patient recruitment in its pivotal phase 3 clinical study of ANX-188 (purified poloxamer 188) in sickle cell disease …
Read more on PR Newswire (press release)